Department of Justice requests additional information on March 31 related to Hart-Scott-Rodino clearance of Healtheon/WebMD's proposed acquisition of Quintiles' electronic data interchange unit Envoy. Quintiles expects the deal to close in the second quarter as originally planned (1"The Pink Sheet" Jan. 31, p. 29)
You may also be interested in...
Quintiles will convert all aspects of its drug development process, including clinical trial recruitment and physician payment, into web transactions by 2002, the firm indicated during a Jan. 24 conference call announcing its Internet partnership with Healtheon/WebMD.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials